EvaLuation Using Cardiac Insertable Devices And TelephonE in Hypertrophic Cardiomyopathy (ELUCIDATE HCM)-rationale and design: a prospective observational study on incidence of arrhythmias in Sweden.

Published in: BMJ open (2017)

The study was approved by The Regional Ethical Committee in Umeå (protocol number 2017/13-31). The study protocol, including variables and prespecified research questions, the study was registered at Clinical Trial Registration NCT03259113. Each patient is informed about the study in both oral and written form by a physician and included after written consent.

Keyphrases

hypertrophic cardiomyopathy
clinical trial
study protocol
randomized controlled trial
left ventricular
primary care
emergency department
heart failure
decision making
phase ii
drug administration